Harbour BioMed Announces Resubmission of Biologics License Application for Batoclimab to NMPA for Treatment of Generalized Myasthenia Gravis ...Middle East

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, June 26, 2024 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and...

Hence then, the article about harbour biomed announces resubmission of biologics license application for batoclimab to nmpa for treatment of generalized myasthenia gravis was published today ( Thursday 27/06/2024 - 02:21 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Harbour BioMed Announces Resubmission of Biologics License Application for Batoclimab to NMPA for Treatment of Generalized Myasthenia Gravis )

Also on site :

• Suspect in deadly San Jose police shooting identified
• South Africa pushes for renewable energy investment
• Zelensky is ‘a man in a desperate position’ – Orban